2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$2.37-$0.13 (-5.20%)
Price as of Oct 22, 2026 7:56 PM EDT- $147.7MMarket Cap
- -51.83%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$2.37-$0.13 (-5.20%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.50 | ||
Change | -$0.06 (-2.34%) | ||
Open | $2.57 | ||
High | $2.61 | ||
Low | $2.49 | ||
Previous Close | $2.56 | ||
Volume | 971,159 | ||
30-Day Average Volume | 1,559,172 | ||
1-Week Change | 0.81% | ||
1-Month Change | -28.77% | ||
1-Year Change | -51.83% | ||
3-Year Change | 76.68% | ||
5-Year Change | -64.54% | ||
Fundamentals | |||
Shares Outstanding | 59.1M | ||
Total Assets | $176.1M | ||
Market Cap | $147.7M | ||
Enterprise Value | $130.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $131.1M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue